Pfizer, BioNTech ink U.K. supply pact for 30 million COVID-19 vaccine doses

Pfizer and BioNTech inked a deal with the U.K. government to supply 30 million doses of an mRNA-based COVID-19 vaccine hopeful over the next two years, the partners said in a joint release Monday.